WO2018236128A3 - Infectious norovirus screening method - Google Patents

Infectious norovirus screening method Download PDF

Info

Publication number
WO2018236128A3
WO2018236128A3 PCT/KR2018/006914 KR2018006914W WO2018236128A3 WO 2018236128 A3 WO2018236128 A3 WO 2018236128A3 KR 2018006914 W KR2018006914 W KR 2018006914W WO 2018236128 A3 WO2018236128 A3 WO 2018236128A3
Authority
WO
WIPO (PCT)
Prior art keywords
screening method
norovirus
infectious norovirus
infectious
present
Prior art date
Application number
PCT/KR2018/006914
Other languages
French (fr)
Korean (ko)
Other versions
WO2018236128A2 (en
Inventor
김두운
김송학
Original Assignee
전남대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 전남대학교 산학협력단 filed Critical 전남대학교 산학협력단
Publication of WO2018236128A2 publication Critical patent/WO2018236128A2/en
Publication of WO2018236128A3 publication Critical patent/WO2018236128A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention provides an infectious norovirus screening method. The present invention allows the relationship between norovirus infection and the occurrence of disease to be researched in the laboratory.
PCT/KR2018/006914 2017-06-19 2018-06-19 Infectious norovirus screening method WO2018236128A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2017-0077476 2017-06-19
KR1020170077476A KR101966525B1 (en) 2017-06-19 2017-06-19 Method for Distincting Infectious Norovirus

Publications (2)

Publication Number Publication Date
WO2018236128A2 WO2018236128A2 (en) 2018-12-27
WO2018236128A3 true WO2018236128A3 (en) 2019-02-14

Family

ID=64737287

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2018/006914 WO2018236128A2 (en) 2017-06-19 2018-06-19 Infectious norovirus screening method

Country Status (2)

Country Link
KR (1) KR101966525B1 (en)
WO (1) WO2018236128A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130280806A1 (en) * 2010-05-17 2013-10-24 Donald Rubin Mammalian genes involved in infection
US20140315750A1 (en) * 2011-11-15 2014-10-23 The United States Of America, As Represented By The Secretary, Department Of Health Selective detection of norovirus
US20160102136A1 (en) * 2013-05-09 2016-04-14 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Single-domain vhh antibodies directed to norovirus gi.1 and gii.4 and their use
KR20160133067A (en) * 2015-05-11 2016-11-22 전남대학교산학협력단 Methods for Distincting Infections Virus based on Molecular Biomarker and Neutralizing Virus Generating Food Poisoning

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130280806A1 (en) * 2010-05-17 2013-10-24 Donald Rubin Mammalian genes involved in infection
US20140315750A1 (en) * 2011-11-15 2014-10-23 The United States Of America, As Represented By The Secretary, Department Of Health Selective detection of norovirus
US20160102136A1 (en) * 2013-05-09 2016-04-14 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Single-domain vhh antibodies directed to norovirus gi.1 and gii.4 and their use
KR20160133067A (en) * 2015-05-11 2016-11-22 전남대학교산학협력단 Methods for Distincting Infections Virus based on Molecular Biomarker and Neutralizing Virus Generating Food Poisoning

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
VASHIST, SURENDER ET AL.: "Molecular Chaperone Hsp90 Is a Therapeutic Target for Noroviruses", JOURNAL OF VIROLOGY, vol. 89, no. 12, 2015, pages 6352 - 6363, XP055572537 *

Also Published As

Publication number Publication date
KR20180138244A (en) 2018-12-31
KR101966525B1 (en) 2019-04-08
WO2018236128A2 (en) 2018-12-27

Similar Documents

Publication Publication Date Title
PH12019502283A1 (en) Anti-lag3 antibodies
ZA202107931B (en) Anti-tau antibodies and methods of use
EP3661966A4 (en) Anti-cd39 antibodies, compositions comprising anti-cd39 antibodies and methods of using anti-cd39 antibodies
MY191169A (en) Anti-fcrh5 antibodies
EP4335874A3 (en) Anti-hla-g antibodies and use thereof
PH12018500711A1 (en) Anti-pd1 antibodies and methods of use
EP3356416A4 (en) Pd-1 antibodies and uses thereof
PH12017500861A1 (en) Anti-interleukin-33 antibodies and uses thereof
EA201691488A1 (en) ANTIBODY MOLECULES AGAINST PD-1 AND THEIR APPLICATIONS
MX2015012326A (en) Anti-crth2 antibodies and their use.
EP3244825A4 (en) Screw-retained abutment with off-axis feature and methods of making and using same
CL2019002605A1 (en) Formulations containing pd-1 binding proteins and methods of manufacturing the same.
EP3675906A4 (en) Anti-tm4sf1 antibodies and methods of using same
MA43814A (en) ANTI-GITR ANTIBODIES, METHODS AND USES
WO2014197885A3 (en) Inhibitors of complement factor h
EA201600026A1 (en) BACTERIAL HYALURONIDASE AND METHOD FOR ITS PRODUCTION
EP3493731A4 (en) Biosensor disease and infection screening
EP3713289A4 (en) Request processing method, and corresponding entity
CL2017002829A1 (en) Systems and methods to reduce unwanted stray currents.
WO2014130741A3 (en) Nme inhibitors and methods of using nme inhibitors
EP3422073A4 (en) Phase-contrast microscope and imaging method
EP3250919A4 (en) Methods and devices for quantitating blood samples
EP3356418A4 (en) Anti-podocalyxin antibodies and methods of using the same
EP3362963A4 (en) Systems and methods for transactional document processing
WO2018236128A3 (en) Infectious norovirus screening method

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18820921

Country of ref document: EP

Kind code of ref document: A2